Hikma Pharmaceuticals

Hikma Pharmaceuticals, founded in 1978 in Amman, Jordan, by Samih Darwazah, focuses on developing, manufacturing, and marketing a diverse range of pharmaceutical products. Initially concentrated on branded pharmaceuticals in the MENA region, the company expanded its operations in the early 1990s by acquiring a generic pharmaceutical business in the United States and establishing injectable pharmaceutical operations in Portugal. Hikma operates through three main segments: injectables, generics, and branded products, with the injectables segment being the primary revenue driver, supplying hospitals with generic injectable products. North America serves as the company's largest market, followed by the Middle East and North Africa, the United Kingdom, Europe, and other regions. Over the years, Hikma has grown significantly through both organic development and strategic acquisitions.